Semaglutide and tirzepatide are both medications used for medically supervised weight loss, and both work in part by mimicking GLP-1, a natural hormone that regulates appetite and blood sugar. The key difference is that tirzepatide also activates a second hormone receptor, GIP, which appears to give it an edge in average weight loss results for many patients — though the right choice still depends on the individual.
How semaglutide works?
Semaglutide is a GLP-1 receptor agonist, meaning it mimics the naturally occurring GLP-1 hormone that signals fullness to the brain, slows stomach emptying, and helps regulate blood sugar. By activating GLP-1 receptors, semaglutide reduces appetite and cravings, helping patients eat less without the same degree of hunger and food noise that typically accompanies calorie restriction.
How tirzepatide works?
Tirzepatide is a dual-receptor agonist, activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. GIP is another naturally occurring hormone involved in appetite regulation and insulin sensitivity. By targeting both pathways at once, tirzepatide tends to produce a stronger overall effect on appetite suppression and metabolic function, which is reflected in clinical trial data showing tirzepatide patients, on average, losing a somewhat greater percentage of body weight than semaglutide patients over comparable treatment periods.
How do side effects compare?
Both medications share a similar side effect profile, since both work through the GLP-1 pathway: nausea, vomiting, diarrhea, constipation, and other gastrointestinal symptoms are the most commonly reported, especially during the early dose-titration period. Because tirzepatide's dual mechanism is more potent, some patients experience a slightly different side effect intensity, which is part of why dosing is started low and increased gradually under close medical supervision for both medications.
Which one is right for you?
For many patients, tirzepatide's dual-receptor mechanism translates into somewhat greater average weight loss, which makes it an appealing first option for patients focused on maximizing results. That said, individual response varies significantly — some patients respond extremely well to semaglutide and prefer its more established, longer track record, while others do better on tirzepatide's broader mechanism. Cost, insurance coverage, and personal tolerance of gastrointestinal side effects also factor into which medication makes the most sense for a given patient.
Both medications require a personalized titration schedule, regular monitoring, and a plan for protein intake and strength maintenance to protect lean muscle mass during weight loss — all of which our clinical team builds into every weight loss program, regardless of which medication you and your provider choose.
How do you get started?
The right medication, starting dose, and titration schedule depend on your health history, prior GLP-1 experience, and goals. A consultation with our clinical team is the first step toward building a plan that's tailored specifically to you.